PubMed

The Family Atherosclerosis Monitoring In earLY life (FAMILY) study: rationale, design, and baseline data of a study examining the early determinants of atherosclerosis.

Morrison KM, Atkinson SA, Yusuf S, Bourgeois J, McDonald S, McQueen MJ, Persadie R, Hunter B, Pogue J, Teo K; FAMILY investigators.

Am Heart J. 2009 Oct;158(4):533-9. Epub 2009 Aug 28.PMID: 19781411 [PubMed - indexed for MEDLINE]Related articles

Dabigatran versus warfarin in patients with atrial fibrillation.

Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD, Wallentin L; RE-LY Steering Committee and Investigators.

N Engl J Med. 2009 Sep 17;361(12):1139-51. Epub 2009 Aug 30.PMID: 19717844 [PubMed - indexed for MEDLINE]Related articles

Systemic absorption of oral vancomycin in a peripheral blood stem cell transplant patient with severe graft-versus-host disease of the gastrointestinal tract.

Pogue JM, DePestel DD, Kaul DR, Khaled Y, Frame DG.

Transpl Infect Dis. 2009 Oct;11(5):467-70. Epub 2009 Jul 22.PMID: 19638004 [PubMed - in process]Related articles

Evaluating the benefit of event adjudication of cardiovascular outcomes in large simple RCTs.

Pogue J, Walter SD, Yusuf S.

Clin Trials. 2009 Jun;6(3):239-51.PMID: 19528133 [PubMed - indexed for MEDLINE]Related articles

Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study.

Sleight P, Redon J, Verdecchia P, Mancia G, Gao P, Fagard R, Schumacher H, Weber M, Böhm M, Williams B, Pogue J, Koon T, Yusuf S; ONTARGET investigators.

J Hypertens. 2009 Jul;27(7):1360-9.PMID: 19506526 [PubMed - indexed for MEDLINE]Related articles

Effect of telmisartan on renal outcomes: a randomized trial.

Mann JF, Schmieder RE, Dyal L, McQueen MJ, Schumacher H, Pogue J, Wang X, Probstfield JL, Avezum A, Cardona-Munoz E, Dagenais GR, Diaz R, Fodor G, Maillon JM, Rydén L, Yu CM, Teo KK, Yusuf S; TRANSCEND (Telmisartan Randomised Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease) Investigators.

Ann Intern Med. 2009 Jul 7;151(1):1-10, W1-2. Epub 2009 May 18.PMID: 19451556 [PubMed - indexed for MEDLINE]Related articles

Effect of clopidogrel added to aspirin in patients with atrial fibrillation.

ACTIVE Investigators, Connolly SJ, Pogue J, Hart RG, Hohnloser SH, Pfeffer M, Chrolavicius S, Yusuf S.

N Engl J Med. 2009 May 14;360(20):2066-78. Epub 2009 Mar 31.PMID: 19336502 [PubMed - indexed for MEDLINE]Related articlesFree article

The need to test the theories behind the Polypill: rationale behind the Indian Polycap Study.

Xavier D, Pais P, Sigamani A, Pogue J, Afzal R, Yusuf S; Indian Polycap Study (TIPS) Investigators.

Nat Clin Pract Cardiovasc Med. 2009 Feb;6(2):96-7. Epub 2008 Dec 23. No abstract available. PMID: 19104516 [PubMed - indexed for MEDLINE]Related articles

Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range.

Connolly SJ, Pogue J, Eikelboom J, Flaker G, Commerford P, Franzosi MG, Healey JS, Yusuf S; ACTIVE W Investigators.

Circulation. 2008 Nov 11;118(20):2029-37. Epub 2008 Oct 27.PMID: 18955670 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of aspirin dose on ischaemic events and bleeding after percutaneous coronary intervention: insights from the PCI-CURE study.

Jolly SS, Pogue J, Haladyn K, Peters RJ, Fox KA, Avezum A, Gersh BJ, Rupprecht HJ, Yusuf S, Mehta SR.

Eur Heart J. 2009 Apr;30(8):900-7. Epub 2008 Sep 26.PMID: 18819961 [PubMed - indexed for MEDLINE]Related articles

Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial.

Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (TRANSCEND) Investigators, Yusuf S, Teo K, Anderson C, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P.

Lancet. 2008 Sep 27;372(9644):1174-83. Epub 2008 Aug 29. Erratum in: Lancet. 2008 Oct 18;372(9647):1384. PMID: 18757085 [PubMed - indexed for MEDLINE]Related articles

Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial.

Mann JF, Schmieder RE, McQueen M, Dyal L, Schumacher H, Pogue J, Wang X, Maggioni A, Budaj A, Chaithiraphan S, Dickstein K, Keltai M, Metsärinne K, Oto A, Parkhomenko A, Piegas LS, Svendsen TL, Teo KK, Yusuf S; ONTARGET investigators.

Lancet. 2008 Aug 16;372(9638):547-53.PMID: 18707986 [PubMed - indexed for MEDLINE]Related articles

Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial.

POISE Study Group, Devereaux PJ, Yang H, Yusuf S, Guyatt G, Leslie K, Villar JC, Xavier D, Chrolavicius S, Greenspan L, Pogue J, Pais P, Liu L, Xu S, Málaga G, Avezum A, Chan M, Montori VM, Jacka M, Choi P.

Lancet. 2008 May 31;371(9627):1839-47. Epub 2008 May 12.PMID: 18479744 [PubMed - indexed for MEDLINE]Related articles

Telmisartan, ramipril, or both in patients at high risk for vascular events.

ONTARGET Investigators, Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P, Anderson C.

N Engl J Med. 2008 Apr 10;358(15):1547-59. Epub 2008 Mar 31.PMID: 18378520 [PubMed - indexed for MEDLINE]Related articlesFree article

Risks and benefits of oral anticoagulation compared with clopidogrel plus aspirin in patients with atrial fibrillation according to stroke risk: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE-W).

Healey JS, Hart RG, Pogue J, Pfeffer MA, Hohnloser SH, De Caterina R, Flaker G, Yusuf S, Connolly SJ.

Stroke. 2008 May;39(5):1482-6. Epub 2008 Mar 6.PMID: 18323500 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial.

DREAM Trial Investigators, Dagenais GR, Gerstein HC, Holman R, Budaj A, Escalante A, Hedner T, Keltai M, Lonn E, McFarlane S, McQueen M, Teo K, Sheridan P, Bosch J, Pogue J, Yusuf S.

Diabetes Care. 2008 May;31(5):1007-14. Epub 2008 Feb 11.PMID: 18268075 [PubMed - indexed for MEDLINE]Related articlesFree article

Monitoring the ACTIVE-W trial: some issues in monitoring a noninferiority trial.

Cairns JA, Wittes J, Wyse DG, Pogue J, Gent M, Hirsh J, Marler J, Pritchett EL.

Am Heart J. 2008 Jan;155(1):33-41. Epub 2007 Nov 26. Review.PMID: 18082486 [PubMed - indexed for MEDLINE]Related articles

Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy.

Hohnloser SH, Pajitnev D, Pogue J, Healey JS, Pfeffer MA, Yusuf S, Connolly SJ; ACTIVE W Investigators.

J Am Coll Cardiol. 2007 Nov 27;50(22):2156-61. Epub 2007 Nov 13.PMID: 18036454 [PubMed - indexed for MEDLINE]Related articles

Determination of risk factors associated with isolation of linezolid-resistant strains of vancomycin-resistant Enterococcus.

Pogue JM, Paterson DL, Pasculle AW, Potoski BA.

Infect Control Hosp Epidemiol. 2007 Dec;28(12):1382-8. Epub 2007 Nov 1.PMID: 17994519 [PubMed - indexed for MEDLINE]Related articles

Venous thromboembolism in association with features of the metabolic syndrome.

Ray JG, Lonn E, Yi Q, Rathe A, Sheridan P, Kearon C; HOPE-2 investigators, Yusuf S, Arnold MJ, McQueen MJ, Pogue J, Probstfield J, Fodor G, Held C, Micks M, Genest J Jr.

QJM. 2007 Nov;100(11):679-84. Epub 2007 Sep 10.PMID: 17846056 [PubMed - indexed for MEDLINE]Related articlesFree article

Impact of ramipril on the incidence of atrial fibrillation: results of the Heart Outcomes Prevention Evaluation study.

Salehian O, Healey J, Stambler B, Alnemer K, Almerri K, Grover J, Bata I, Mann J, Matthew J, Pogue J, Yusuf S, Dagenais G, Lonn E; HOPE Investigators.

Am Heart J. 2007 Sep;154(3):448-53.PMID: 17719288 [PubMed - indexed for MEDLINE]Related articles

Challenges of establishing new antithrombotic therapies in atrial fibrillation.

Connolly SJ, Eikelboom J, O'Donnell M, Pogue J, Yusuf S.

Circulation. 2007 Jul 24;116(4):449-55. Review. No abstract available. PMID: 17646595 [PubMed - indexed for MEDLINE]Related articlesFree article

Oral anticoagulant and antiplatelet therapy and peripheral arterial disease.

Warfarin Antiplatelet Vascular Evaluation Trial Investigators, Anand S, Yusuf S, Xie C, Pogue J, Eikelboom J, Budaj A, Sussex B, Liu L, Guzman R, Cina C, Crowell R, Keltai M, Gosselin G.

N Engl J Med. 2007 Jul 19;357(3):217-27.PMID: 17634457 [PubMed - indexed for MEDLINE]Related articlesFree article

Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies.

de Koning L, Merchant AT, Pogue J, Anand SS.

Eur Heart J. 2007 Apr;28(7):850-6. Epub 2007 Apr 2. Review.PMID: 17403720 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of long-term ACE-inhibitor therapy in elderly vascular disease patients.

Gianni M, Bosch J, Pogue J, Probstfield J, Dagenais G, Yusuf S, Lonn E.

Eur Heart J. 2007 Jun;28(11):1382-8. Epub 2007 Mar 29.PMID: 17395677 [PubMed - indexed for MEDLINE]Related articlesFree article

Reevaluation by high-performance liquid chromatography: clinical significance of microalbuminuria in individuals at high risk of cardiovascular disease in the Heart Outcomes Prevention Evaluation (HOPE) Study.

McQueen MJ, Gerstein HC, Pogue J, Mann JF, Yusuf S.

Am J Kidney Dis. 2006 Dec;48(6):889-96.PMID: 17162143 [PubMed - indexed for MEDLINE]Related articles

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.

DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone Medication) Trial Investigators, Gerstein HC, Yusuf S, Bosch J, Pogue J, Sheridan P, Dinccag N, Hanefeld M, Hoogwerf B, Laakso M, Mohan V, Shaw J, Zinman B, Holman RR.

Lancet. 2006 Sep 23;368(9541):1096-105. Erratum in: Lancet. 2006 Nov 18;368(9549):1770. PMID: 16997664 [PubMed - indexed for MEDLINE]Related articles

Effect of ramipril on the incidence of diabetes.

DREAM Trial Investigators, Bosch J, Yusuf S, Gerstein HC, Pogue J, Sheridan P, Dagenais G, Diaz R, Avezum A, Lanas F, Probstfield J, Fodor G, Holman RR.

N Engl J Med. 2006 Oct 12;355(15):1551-62. Epub 2006 Sep 15.PMID: 16980380 [PubMed - indexed for MEDLINE]Related articlesFree article

Impact of ramipril on the circadian periodicity of acute myocardial infarction.

Dagenais GR, Pogue J, Teo KK, Lonn EM, Yusuf S; HOPE Study Investigators.

Am J Cardiol. 2006 Sep 15;98(6):758-60. Epub 2006 Jul 28.PMID: 16950179 [PubMed - indexed for MEDLINE]Related articles

Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials.

Dagenais GR, Pogue J, Fox K, Simoons ML, Yusuf S.

Lancet. 2006 Aug 12;368(9535):581-8. Review.PMID: 16905022 [PubMed - indexed for MEDLINE]Related articles

Comparative impact of multiple biomarkers and N-Terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study.

Blankenberg S, McQueen MJ, Smieja M, Pogue J, Balion C, Lonn E, Rupprecht HJ, Bickel C, Tiret L, Cambien F, Gerstein H, Münzel T, Yusuf S; HOPE Study Investigators.

Circulation. 2006 Jul 18;114(3):201-8. Epub 2006 Jul 10.PMID: 16831981 [PubMed - indexed for MEDLINE]Related articlesFree article

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial.

ACTIVE Writing Group of the ACTIVE Investigators, Connolly S, Pogue J, Hart R, Pfeffer M, Hohnloser S, Chrolavicius S, Pfeffer M, Hohnloser S, Yusuf S.

Lancet. 2006 Jun 10;367(9526):1903-12.PMID: 16765759 [PubMed - indexed for MEDLINE]Related articles

Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial.

Yusuf S, Mehta SR, Chrolavicius S, Afzal R, Pogue J, Granger CB, Budaj A, Peters RJ, Bassand JP, Wallentin L, Joyner C, Fox KA; OASIS-6 Trial Group.

JAMA. 2006 Apr 5;295(13):1519-30. Epub 2006 Mar 14.PMID: 16537725 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparison of fondaparinux and enoxaparin in acute coronary syndromes.

Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators, Yusuf S, Mehta SR, Chrolavicius S, Afzal R, Pogue J, Granger CB, Budaj A, Peters RJ, Bassand JP, Wallentin L, Joyner C, Fox KA.

N Engl J Med. 2006 Apr 6;354(14):1464-76. Epub 2006 Mar 14.PMID: 16537663 [PubMed - indexed for MEDLINE]Related articlesFree article

Homocysteine lowering with folic acid and B vitamins in vascular disease.

Lonn E, Yusuf S, Arnold MJ, Sheridan P, Pogue J, Micks M, McQueen MJ, Probstfield J, Fodor G, Held C, Genest J Jr; Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators.

N Engl J Med. 2006 Apr 13;354(15):1567-77. Epub 2006 Mar 12. Erratum in: N Engl J Med. 2006 Aug 17;355(7):746. PMID: 16531613 [PubMed - indexed for MEDLINE]Related articlesFree article

Rationale, design and baseline characteristics of a large, simple, randomized trial of combined folic acid and vitamins B6 and B12 in high-risk patients: the Heart Outcomes Prevention Evaluation (HOPE)-2 trial.

Lonn E, Held C, Arnold JM, Probstfield J, McQueen M, Micks M, Pogue J, Sheridan P, Bosch J, Genest J, Yusuf S; HOPE-2 Investigators.

Can J Cardiol. 2006 Jan;22(1):47-53.PMID: 16450017 [PubMed - indexed for MEDLINE]Related articlesFree article

Two-year outcomes in patients admitted with non-ST elevation acute coronary syndrome: results of the OASIS registry 1 and 2.

Prabhakaran D, Yusuf S, Mehta S, Pogue J, Avezum A, Budaj A, Cerumzynski L, Flather M, Fox K, Hunt D, Lisheng L, Keltai M, Parkhomenko A, Pais P, Reddy S, Ruda M, Hiquing T, Jun Z.

Indian Heart J. 2005 May-Jun;57(3):217-25.PMID: 16196178 [PubMed - indexed for MEDLINE]Related articles

Long-term effects of ramipril on cardiovascular events and on diabetes: results of the HOPE study extension.

Bosch J, Lonn E, Pogue J, Arnold JM, Dagenais GR, Yusuf S; HOPE/HOPE-TOO Study Investigators.

Circulation. 2005 Aug 30;112(9):1339-46.PMID: 16129815 [PubMed - indexed for MEDLINE]Related articlesFree article

The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysis.

Gerstein HC, Pogue J, Mann JF, Lonn E, Dagenais GR, McQueen M, Yusuf S; HOPE investigators.

Diabetologia. 2005 Sep;48(9):1749-55. Epub 2005 Jul 30.PMID: 16059716 [PubMed - indexed for MEDLINE]Related articles

Effect of angiotensin-converting enzyme inhibition on functional class in patients with left ventricular systolic dysfunction--a meta-analysis.

Abdulla J, Pogue J, Abildstrøm SZ, Køber L, Christensen E, Pfeffer MA, Yusuf S, Torp-Pedersen C.

Eur J Heart Fail. 2006 Jan;8(1):90-6. Epub 2005 Jul 27.PMID: 16054435 [PubMed - indexed for MEDLINE]Related articles

Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial.

Lonn E, Bosch J, Yusuf S, Sheridan P, Pogue J, Arnold JM, Ross C, Arnold A, Sleight P, Probstfield J, Dagenais GR; HOPE and HOPE-TOO Trial Investigators.

JAMA. 2005 Mar 16;293(11):1338-47.PMID: 15769967 [PubMed - indexed for MEDLINE]Related articlesFree article

ACE inhibition in stable coronary artery disease.

Yusuf S, Pogue J.

N Engl J Med. 2005 Mar 3;352(9):937-9; author reply 937-9. No abstract available. PMID: 15745989 [PubMed - indexed for MEDLINE]Related articles

Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial.

Mehta SR, Yusuf S, Díaz R, Zhu J, Pais P, Xavier D, Paolasso E, Ahmed R, Xie C, Kazmi K, Tai J, Orlandini A, Pogue J, Liu L; CREATE-ECLA Trial Group Investigators.

JAMA. 2005 Jan 26;293(4):437-46.PMID: 15671428 [PubMed - indexed for MEDLINE]Related articlesFree article

Prognostic impact of body weight and abdominal obesity in women and men with cardiovascular disease.

Dagenais GR, Yi Q, Mann JF, Bosch J, Pogue J, Yusuf S.

Am Heart J. 2005 Jan;149(1):54-60.PMID: 15660034 [PubMed - indexed for MEDLINE]Related articles

Editorials and opinions "crossing the bar" versus limbo.

Pogue JF.

Healthc Leadersh Rep. 2004 Nov;12(11):15-6. No abstract available. PMID: 15656155 [PubMed - indexed for MEDLINE]Related articles

Getting fitted for gumshoes. In order to remain fraud-free, providers are best off investigating themselves.

Pogue JF.

Healthc Leadersh Rep. 2004 Oct;12(10):15-6. No abstract available. PMID: 15586720 [PubMed - indexed for MEDLINE]Related articles

The first helicopter out: with choices narrowing, Americans will inevitably go overseas for care.

Pogue JF.

Healthc Leadersh Rep. 2004 Sep;12(9):15-6. No abstract available. PMID: 15553203 [PubMed - indexed for MEDLINE]Related articles

The effect of vitamin E supplementation on cardiovascular risk in diabetic individuals with different haptoglobin phenotypes.

Levy AP, Gerstein HC, Miller-Lotan R, Ratner R, McQueen M, Lonn E, Pogue J.

Diabetes Care. 2004 Nov;27(11):2767. No abstract available. PMID: 15505023 [PubMed - indexed for MEDLINE]Related articlesFree article

Nursing homes are hot commodities for all the wrong reasons.

Pogue JF.

Healthc Leadersh Rep. 2004 Aug;12(8):15-6. No abstract available. PMID: 15460396 [PubMed - indexed for MEDLINE]Related articles

A narrowing door: hospitals, faced with ever-growing demand, may have to consider admission alternatives.

Pogue JF.

Healthc Leadersh Rep. 2004 Jul;12(7):15-6. No abstract available. PMID: 15449870 [PubMed - indexed for MEDLINE]Related articles